Advertisement

Chronic Obstructive Pulmonary Disease in Elderly Patients

Published:August 22, 2017DOI:https://doi.org/10.1016/j.cger.2017.06.006

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Geriatric Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. Available at: http://goldcopd.org. Accessed November 1, 2016.

        • Tilert T.
        • Dillon C.
        • Paulose-Ram R.
        • et al.
        Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
        Respir Res. 2013; 14: 103
      2. Centers for Disease Control and Prevention NCHS, 1998-2009. Available at: http://www.cdc.gov/nchs/data/databriefs/db63_tables.pdf#2. Accessed November 18, 2016.

        • Menezes A.M.
        • Perez-Padilla R.
        • Jardim J.R.
        • et al.
        Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.
        Lancet. 2005; 366: 1875-1881
        • Buist A.S.
        • McBurnie M.A.
        • Vollmer W.M.
        • et al.
        International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.
        Lancet. 2007; 370: 741-750
        • Vos T.
        • Flaxman A.D.
        • Naghavi M.
        • et al.
        Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010.
        Lancet. 2012; 380: 2163-2196
        • Lopez-Campos J.L.
        • Tan W.
        • Soriano J.B.
        Global burden of COPD.
        Respirology. 2016; 21: 14-23
        • Salvi S.S.
        • Barnes P.J.
        Chronic obstructive pulmonary disease in non-smokers.
        Lancet. 2009; 374: 733-743
        • Mathers C.D.
        • Loncar D.
        Projections of global mortality and burden of disease from 2002 to 2030.
        PLoS Med. 2006; 3: e442
        • Talamo C.
        • de Oca M.M.
        • Halbert R.
        • et al.
        Diagnostic labeling of COPD in five Latin American cities.
        Chest. 2007; 131: 60-67
        • Lamprecht B.
        • Soriano J.B.
        • Studnicka M.
        • et al.
        Determinants of underdiagnosis of COPD in national and international surveys.
        Chest. 2015; 148: 971-985
        • Damarla M.
        • Celli B.R.
        • Mullerova H.X.
        • et al.
        Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure.
        Respir Care. 2006; 51: 1120-1124
        • Mannino D.M.
        COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.
        Chest. 2002; 121: 121S-126S
        • Murray C.J.
        • Lopez A.D.
        Measuring the global burden of disease.
        N Engl J Med. 2013; 369: 448-457
      3. 2nd edition. The lung: scientific foundations. vol. 2. Lippincott-Raven, Philadelphia1997: 2193-2203
        • Kirkwood T.B.
        Understanding the odd science of aging.
        Cell. 2005; 120: 437-447
        • Harman D.
        Free radical theory of aging: an update: increasing the functional life span.
        Ann N Y Acad Sci. 2006; 1067: 10-21
        • Divo M.
        • Cote C.
        • de Torres J.P.
        • et al.
        Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2012; 186: 155-161
        • Mercado N.
        • Ito K.
        • Barnes P.J.
        Accelerated ageing of the lung in COPD: new concepts.
        Thorax. 2015; 70: 482-489
        • Rutten E.P.
        • Gopal P.
        • Wouters E.F.
        • et al.
        Various mechanistic pathways representing the aging process are altered in COPD.
        Chest. 2016; 149: 53-61
        • Sabit R.
        • Bolton C.E.
        • Edwards P.H.
        • et al.
        Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2007; 175: 1259-1265
        • Celli B.R.
        • Halbert R.J.
        • Nordyke R.J.
        • et al.
        Airway obstruction in never smokers: results from the third national health and nutrition examination survey.
        Am J Med. 2005; 118: 1364-1372
        • Marcus B.S.
        • McAvay G.
        • Gill T.M.
        • et al.
        Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.
        J Am Geriatr Soc. 2015; 63: 251-257
        • Celli B.R.
        • MacNee W.
        • Force A.E.T.
        Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
        Eur Respir J. 2004; 23: 932-946
        • Qaseem A.
        • Wilt T.J.
        • Weinberger S.E.
        • et al.
        Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
        Ann Intern Med. 2011; 155: 179-191
        • Hansen J.E.
        • Sun X.G.
        • Wasserman K.
        Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%.
        Chest. 2007; 131: 349-355
        • Vaz Fragoso C.A.
        • Concato J.
        • McAvay G.
        • et al.
        The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2010; 181: 446-451
        • Stanojevic S.
        • Wade A.
        • Stocks J.
        • et al.
        Reference ranges for spirometry across all ages: a new approach.
        Am J Respir Crit Care Med. 2008; 177: 253-260
        • Turkeshi E.
        • Vaes B.
        • Andreeva E.
        • et al.
        Airflow limitation by the global lungs initiative equations in a cohort of very old adults.
        Eur Respir J. 2015; 46: 123-132
        • Casanova C.
        • Cote C.
        • de Torres J.P.
        • et al.
        Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2005; 171: 591-597
        • Casaburi R.
        • Maltais F.
        • Porszasz J.
        • et al.
        Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
        Ann Am Thorac Soc. 2014; 11: 1351-1361
        • Holland A.E.
        • Spruit M.A.
        • Troosters T.
        • et al.
        An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.
        Eur Respir J. 2014; 44: 1428-1446
        • Pinto-Plata V.M.
        • Cote C.
        • Cabral H.
        • et al.
        The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.
        Eur Respir J. 2004; 23: 28-33
        • Polkey M.I.
        • Spruit M.A.
        • Edwards L.D.
        • et al.
        Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.
        Am J Respir Crit Care Med. 2013; 187: 382-386
        • Celli B.R.
        • Cote C.G.
        • Marin J.M.
        • et al.
        The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
        N Engl J Med. 2004; 350: 1005-1012
        • Detterbeck F.C.
        • Mazzone P.J.
        • Naidich D.P.
        • et al.
        Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: e78S-e92
        • Gonzalez J.
        • Marin M.
        • Sanchez-Salcedo P.
        • et al.
        Lung cancer screening in patients with chronic obstructive pulmonary disease.
        Ann Transl Med. 2016; 4: 160
        • Rodriguez-Roisin R.
        Toward a consensus definition for COPD exacerbations.
        Chest. 2000; 117: 398S-401S
        • Stevenson N.J.
        • Walker P.P.
        • Costello R.W.
        • et al.
        Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2005; 172: 1510-1516
        • Parker C.M.
        • Voduc N.
        • Aaron S.D.
        • et al.
        Physiological changes during symptom recovery from moderate exacerbations of COPD.
        Eur Respir J. 2005; 26: 420-428
        • Pinto-Plata V.M.
        • Livnat G.
        • Girish M.
        • et al.
        Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD.
        Chest. 2007; 131: 37-43
        • Rodriguez-Roisin R.
        • Drakulovic M.
        • Rodriguez D.A.
        • et al.
        Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity.
        J Appl Physiol (1985). 2009; 106: 1902-1908
        • Wells J.M.
        • Washko G.R.
        • Han M.K.
        • et al.
        Pulmonary arterial enlargement and acute exacerbations of COPD.
        N Engl J Med. 2012; 367: 913-921
        • Cote C.G.
        • Dordelly L.J.
        • Celli B.R.
        Impact of COPD exacerbations on patient-centered outcomes.
        Chest. 2007; 131: 696-704
        • Soler-Cataluna J.J.
        • Martinez-Garcia M.A.
        • Roman Sanchez P.
        • et al.
        Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
        Thorax. 2005; 60: 925-931
        • van Eerd E.A.
        • van der Meer R.M.
        • van Schayck O.C.
        • et al.
        Smoking cessation for people with chronic obstructive pulmonary disease.
        Cochrane Database Syst Rev. 2016; (CD010744)
        • Wongsurakiat P.
        • Maranetra K.N.
        • Wasi C.
        • et al.
        Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.
        Chest. 2004; 125: 2011-2020
        • Nichol K.L.
        • Margolis K.L.
        • Wuorenma J.
        • et al.
        The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
        N Engl J Med. 1994; 331: 778-784
        • Walters J.A.
        • Smith S.
        • Poole P.
        • et al.
        Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.
        Cochrane Database Syst Rev. 2010; (CD001390)
        • Dransfield M.T.
        • Harnden S.
        • Burton R.L.
        • et al.
        Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.
        Clin Infect Dis. 2012; 55: e35-e44
        • Restrepo R.D.
        • Alvarez M.T.
        • Wittnebel L.D.
        • et al.
        Medication adherence issues in patients treated for COPD.
        Int J Chron Obstruct Pulmon Dis. 2008; 3: 371-384
        • Al-Showair R.A.
        • Tarsin W.Y.
        • Assi K.H.
        • et al.
        Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?.
        Respir Med. 2007; 101: 2395-2401
        • Barrons R.
        • Pegram A.
        • Borries A.
        Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
        Am J Health Syst Pharm. 2011; 68: 1221-1232
        • Zarowitz B.J.
        • O'Shea T.
        Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment.
        J Manag Care Pharm. 2012; 18: 598-606
        • Atkins P.J.
        Dry powder inhalers: an overview.
        Respir Care. 2005; 50 ([discussion: 1312]): 1304-1312
        • Lavorini F.
        • Magnan A.
        • Dubus J.C.
        • et al.
        Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.
        Respir Med. 2008; 102: 593-604
        • Dolovich M.B.
        • Dhand R.
        Aerosol drug delivery: developments in device design and clinical use.
        Lancet. 2011; 377: 1032-1045
        • Taffet G.E.
        • Donohue J.F.
        • Altman P.R.
        Considerations for managing chronic obstructive pulmonary disease in the elderly.
        Clin Interv Aging. 2014; 9: 23-30
        • Martinez F.J.
        • Calverley P.M.
        • Goehring U.M.
        • et al.
        Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
        Lancet. 2015; 385: 857-866
        • Albert R.K.
        • Connett J.
        • Bailey W.C.
        • et al.
        Azithromycin for prevention of exacerbations of COPD.
        N Engl J Med. 2011; 365: 689-698
        • Spruit M.A.
        • Singh S.J.
        • Garvey C.
        • et al.
        An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
        Am J Respir Crit Care Med. 2013; 188: e13-e64
        • Yohannes A.M.
        Pulmonary rehabilitation and outcome measures in elderly patients with chronic obstructive pulmonary disease.
        Gerontology. 2001; 47: 241-245
        • Mador M.J.
        • Bozkanat E.
        • Aggarwal A.
        • et al.
        Endurance and strength training in patients with COPD.
        Chest. 2004; 125: 2036-2045
        • Fiatarone M.A.
        • O'Neill E.F.
        • Ryan N.D.
        • et al.
        Exercise training and nutritional supplementation for physical frailty in very elderly people.
        N Engl J Med. 1994; 330: 1769-1775
        • Chang S.S.
        • Chen S.
        • McAvay G.J.
        • et al.
        Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.
        J Am Geriatr Soc. 2012; 60: 1839-1846
        • Ries A.L.
        • Kaplan R.M.
        • Myers R.
        • et al.
        Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial.
        Am J Respir Crit Care Med. 2003; 167: 880-888
        • Griffiths T.L.
        • Burr M.L.
        • Campbell I.A.
        • et al.
        Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.
        Lancet. 2000; 355: 362-368
        • Guell M.R.
        • Cejudo P.
        • Ortega F.
        • et al.
        Benefits of long-term pulmonary rehabilitation maintenance program in severe COPD patients: 3 year follow-up.
        Am J Respir Crit Care Med. 2017; 195: 622-629
        • Lajoie Y.
        • Gallagher S.P.
        Predicting falls within the elderly community: comparison of postural sway, reaction time, the berg balance scale and the activities-specific balance confidence (ABC) scale for comparing fallers and non-fallers.
        Arch Gerontol Geriatr. 2004; 38: 11-26
        • Podsiadlo D.
        • Richardson S.
        The timed “Up & Go”: a test of basic functional mobility for frail elderly persons.
        J Am Geriatr Soc. 1991; 39: 142-148
        • Siouta N.
        • van Beek K.
        • Preston N.
        • et al.
        Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways.
        BMC Palliat Care. 2016; 15: 18
        • Curtis J.R.
        Palliative and end-of-life care for patients with severe COPD.
        Eur Respir J. 2008; 32: 796-803